title: Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration.
abstract: BACKGROUND
  Circulating MCP-1 concentration was found to be increased in cardiovascular diseases and is of high interest in the list of biomarkers of atherosclerosis. TNF-alpha, LT-alpha, IL-1alpha and IL-1beta are four proinflammatory cytokines that regulate MCP-1 concentration in vitro. We hypothesized that specific genetic polymorphisms in TNF, LTA, IL-1A and IL-1B genes could modulate plasma MCP-1 concentration.
  
  
  METHODS
  Plasma MCP-1 concentration was quantified with a biochip array analyzer in 395 adults from the Stanislas family study. TNF -308G>A, LTA 252A>G (A=TNFB2, G=TNFB1), IL-1A -889C>T and IL-1B 3954C>T were genotyped with a prototypic multilocus genotyping assay.
  
  
  RESULTS
  Among the four polymorphisms studied only LTA 252A>G and TNF -308G>A were significantly associated with plasma MCP-1 concentration (p=0.005 and p=0.038, respectively) after adjustment for covariates (age, sex, smoking, monocyte count and hematocrit). Carriers of the 252A allele or the -308G had lower MCP-1 concentrations than carriers of the 252G or the -308A alleles, respectively. Moreover, as TNF and LTA genes were in linkage disequilibrium, the TNF bloc haplotypes were compared with respect to MCP-1 concentration, and a significant association (p=0.021) was observed, due only to the LTA polymorphism. This association remained significant even after adjustment for TNF-alpha and hs-CRP concentrations.
  
  
  CONCLUSIONS
  A functional polymorphism within the TNF bloc could modulate MCP-1 concentration and seems more likely to be near to the LTA 252A>G polymorphism than to the TNF -308G>A one. In addition, the association found in healthy French adults is independent of other actors of inflammation such as TNF-alpha and hs-CRP.
authors.affiliation: INSERM, U525, Equipe 4, Nancy, France.
authors.forename: Hind
authors.initials: H
authors.lastname: Berrahmoune
authors.forename: Bernard
authors.initials: B
authors.lastname: Herbeth
authors.forename: John V
authors.initials: JV
authors.lastname: Lamont
authors.forename: Peter S
authors.initials: PS
authors.lastname: Fitzgerald
authors.forename: Sophie
authors.initials: S
authors.lastname: Visvikis-Siest
mesh_terms: D000328:Adult; D018932:Chemokine CCL2 / Q000097:blood*; D005260:Female; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D007375:Interleukin-1 / Q000235:genetics*; D053582:Interleukin-1alpha / Q000235:genetics; D053583:Interleukin-1beta / Q000235:genetics; D008233:Lymphotoxin-alpha / Q000235:genetics; D008297:Male; D011110:Polymorphism, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D018932:Chemokine CCL2; D007375:Interleukin-1; D053582:Interleukin-1alpha; D053583:Interleukin-1beta; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha